Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Initial insulin therapy vs guideline-based treatment in early-onset severe insulin-deficient diabetes
ChiCTR2100054883Phase 4Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of human insulin in diabetes mellitus (DM) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: HbA1c. Started Jan 2022; status: recruiting.
02
Drugs
human insulin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on ChiCTR2100054883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054883.